294 related articles for article (PubMed ID: 18291408)
1. Electrostatic interactions and ionization effect in immobilized artificial membrane retention. A comparative study with octanol-water partitioning.
Vrakas D; Giaginis C; Tsantili-Kakoulidou A
J Chromatogr A; 2008 Apr; 1187(1-2):67-78. PubMed ID: 18291408
[TBL] [Abstract][Full Text] [Related]
2. Different retention behavior of structurally diverse basic and neutral drugs in immobilized artificial membrane and reversed-phase high performance liquid chromatography: comparison with octanol-water partitioning.
Vrakas D; Giaginis C; Tsantili-Kakoulidou A
J Chromatogr A; 2006 May; 1116(1-2):158-64. PubMed ID: 16595136
[TBL] [Abstract][Full Text] [Related]
3. Comparison between immobilized artificial membrane (IAM) HPLC data and lipophilicity in n-octanol for quinolone antibacterial agents.
Barbato F; Cirocco V; Grumetto L; Immacolata La Rotonda M
Eur J Pharm Sci; 2007 Aug; 31(5):288-97. PubMed ID: 17540545
[TBL] [Abstract][Full Text] [Related]
4. Lipophilic and electrostatic forces encoded in IAM-HPLC indexes of basic drugs: their role in membrane partition and their relationships with BBB passage data.
Grumetto L; Carpentiero C; Barbato F
Eur J Pharm Sci; 2012 Apr; 45(5):685-92. PubMed ID: 22306648
[TBL] [Abstract][Full Text] [Related]
5. Octanol/water partitioning simulation by reversed-phase high performance liquid chromatography for structurally diverse acidic drugs: Effect of n-octanol as mobile phase additive.
Giaginis C; Theocharis S; Tsantili-Kakoulidou A
J Chromatogr A; 2007 Sep; 1166(1-2):116-25. PubMed ID: 17719594
[TBL] [Abstract][Full Text] [Related]
6. Can protonated beta-blockers interact with biomembranes stronger than neutral isolipophilic compounds? A chromatographic study on three different phospholipid stationary phases (IAM-HPLC).
Barbato F; di Martino G; Grumetto L; La Rotonda MI
Eur J Pharm Sci; 2005; 25(4-5):379-86. PubMed ID: 15979535
[TBL] [Abstract][Full Text] [Related]
7. The potential of immobilized artificial membrane chromatography to predict human oral absorption.
Tsopelas F; Vallianatou T; Tsantili-Kakoulidou A
Eur J Pharm Sci; 2016 Jan; 81():82-93. PubMed ID: 26485055
[TBL] [Abstract][Full Text] [Related]
8. Lipophilic and polar interaction forces between acidic drugs and membrane phospholipids encoded in IAM-HPLC indexes: their role in membrane partition and relationships with BBB permeation data.
Grumetto L; Carpentiero C; Di Vaio P; Frecentese F; Barbato F
J Pharm Biomed Anal; 2013 Mar; 75():165-72. PubMed ID: 23261809
[TBL] [Abstract][Full Text] [Related]
9. Prediction of drug-membrane interactions by IAM-HPLC: effects of different phospholipid stationary phases on the partition of bases.
Barbato F; di Martino G; Grumetto L; La Rotonda MI
Eur J Pharm Sci; 2004 Jul; 22(4):261-9. PubMed ID: 15196582
[TBL] [Abstract][Full Text] [Related]
10. Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs.
Kotecha J; Shah S; Rathod I; Subbaiah G
Int J Pharm; 2007 Mar; 333(1-2):127-35. PubMed ID: 17095172
[TBL] [Abstract][Full Text] [Related]
11. Insight into the retention mechanism on immobilized artificial membrane chromatography using two stationary phases.
Tsopelas F; Malaki N; Vallianatou T; Chrysanthakopoulos M; Vrakas D; Ochsenkühn-Petropoulou M; Tsantili-Kakoulidou A
J Chromatogr A; 2015 May; 1396():25-33. PubMed ID: 25911385
[TBL] [Abstract][Full Text] [Related]
12. Molecular factors influencing retention on immobilized artifical membranes (IAM) compared to partitioning in liposomes and n-octanol.
Taillardat-Bertschinger A; Martinet CA; Carrupt PA; Reist M; Caron G; Fruttero R; Testa B
Pharm Res; 2002 Jun; 19(6):729-37. PubMed ID: 12134941
[TBL] [Abstract][Full Text] [Related]
13. Statins (HMG-coenzyme A reductase inhibitors)-biomimetic membrane binding mechanism investigated by molecular chromatography.
Sarr FS; André C; Guillaume YC
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 868(1-2):20-7. PubMed ID: 18479982
[TBL] [Abstract][Full Text] [Related]
14. Prediction and mechanism elucidation of analyte retention on phospholipid stationary phases (IAM-HPLC) by in silico calculated physico-chemical descriptors.
Russo G; Grumetto L; Barbato F; Vistoli G; Pedretti A
Eur J Pharm Sci; 2017 Mar; 99():173-184. PubMed ID: 27919703
[TBL] [Abstract][Full Text] [Related]
15. Indexes of polar interactions between ionizable drugs and membrane phospholipids measured by IAM-HPLC: their relationships with data of Blood-Brain Barrier passage.
Grumetto L; Russo G; Barbato F
Eur J Pharm Sci; 2014 Dec; 65():139-46. PubMed ID: 25262853
[TBL] [Abstract][Full Text] [Related]
16. Quantitative structure-retention relationship studies with immobilized artificial membrane chromatography II: partial least squares regression.
Li J; Sun J; He Z
J Chromatogr A; 2007 Jan; 1140(1-2):174-9. PubMed ID: 17161410
[TBL] [Abstract][Full Text] [Related]
17. Immobilized artificial membrane chromatography with mass spectrometric detection: a rapid method for screening drug-membrane interactions.
Liu H; Carter GT; Tischler M
Rapid Commun Mass Spectrom; 2001; 15(17):1533-8. PubMed ID: 11544589
[TBL] [Abstract][Full Text] [Related]
18. Capillary electrochromatography as a new tool to assess drug affinity for membrane phospholipids.
Barbato F; Grumetto L; Carpentiero C; Rocco A; Fanali S
J Pharm Biomed Anal; 2011 Apr; 54(5):893-9. PubMed ID: 21168987
[TBL] [Abstract][Full Text] [Related]
19. The performance of 1-ethyl-3-methylimidazolium tetrafluoroborate ionic liquid as mobile phase additive in HPLC-based lipophilicity assessment.
Giaginis C; Tsantili-Kakoulidou A
Biomed Chromatogr; 2011 May; 25(5):606-12. PubMed ID: 20740480
[TBL] [Abstract][Full Text] [Related]
20. The use of immobilized artificial membrane chromatography to predict bioconcentration of pharmaceutical compounds.
Tsopelas F; Stergiopoulos C; Tsakanika LA; Ochsenkühn-Petropoulou M; Tsantili-Kakoulidou A
Ecotoxicol Environ Saf; 2017 May; 139():150-157. PubMed ID: 28130991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
